drugset / Trial / NCT00949065

Intravenous Immunoglobulins in Complex-regional Pain Syndrome

NCT00949065

Phase 3 Withdrawn University of Giessen
RandomizedCrossoverQuadruple-blindTreatment

Summary

The purpose of this study is to determine whether intravenous immunoglobulins are effective in the treatment of complex-regional pain syndrome.

Timeline

Start
2009-08
Primary completion
2011-01
Completion
2011-02-15

Drugs

EvaluationDrugModalityDoseRoute
Comparator Immune Globulin Intravenous (Human) Protein / enzyme biologic 0.36 g/kg Intravenous
Comparator Immune Globulin Intravenous (Human) Protein / enzyme biologic 0.44 g/kg Intravenous